- Home
- CRIS vs NOM Comparison
CRIS vs NOM Comparison
Compare CRIS & NOM Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CRIS
- NOM
- Stock Information
- Founded
- CRIS 2000
- NOM 1993
- Country
- CRIS United States
- NOM United States
- Employees
- CRIS N/A
- NOM N/A
- Industry
- CRIS Biotechnology: Biological Products (No Diagnostic Substances)
- NOM Investment Managers
- Sector
- CRIS Health Care
- NOM Finance
- Exchange
- CRIS Nasdaq
- NOM Nasdaq
- Market Cap
- CRIS 22.9M
- NOM 25.8M
- IPO Year
- CRIS 2000
- NOM N/A
- Fundamental
- Price
- CRIS $1.77
- NOM $11.24
- Analyst Decision
- CRIS Strong Buy
- NOM
- Analyst Count
- CRIS 2
- NOM 0
- Target Price
- CRIS $16.50
- NOM N/A
- AVG Volume (30 Days)
- CRIS 75.9K
- NOM 6.9K
- Earning Date
- CRIS 11-13-2025
- NOM 01-01-0001
- Dividend Yield
- CRIS N/A
- NOM 3.39%
- EPS Growth
- CRIS N/A
- NOM N/A
- EPS
- CRIS N/A
- NOM N/A
- Revenue
- CRIS $11,405,000.00
- NOM N/A
- Revenue This Year
- CRIS $1.41
- NOM N/A
- Revenue Next Year
- CRIS $7.46
- NOM N/A
- P/E Ratio
- CRIS N/A
- NOM N/A
- Revenue Growth
- CRIS 12.24
- NOM N/A
- 52 Week Low
- CRIS $1.02
- NOM $8.52
- 52 Week High
- CRIS $6.44
- NOM $10.48
- Technical
- Relative Strength Index (RSI)
- CRIS 52.53
- NOM 60.99
- Support Level
- CRIS $1.63
- NOM $10.84
- Resistance Level
- CRIS $1.95
- NOM $11.26
- Average True Range (ATR)
- CRIS 0.14
- NOM 0.18
- MACD
- CRIS 0.02
- NOM 0.03
- Stochastic Oscillator
- CRIS 45.59
- NOM 89.03
About CRIS Curis Inc.
Curis Inc is a biotechnology company that develops and commercializes drugs and therapies in the immuno-oncology and precision oncology therapeutic areas. The company targets solid tumors, diffuse large B-cell lymphoma, solid tumors or lymphomas, hematological cancers, and others. Its pipeline products include Fimepinostat, CA-170, CA-4948, CA-327, and Erivedge.
About NOM Nuveen Missouri Quality Municipal Income Fund
Nuveen Missouri Quality Municipal Income Fund is a diversified, closed-end management investment company operating in the United States. The Fund's investment objective is current income exempt from both regular federal income taxes and Missouri personal income taxes, and to enhance portfolio value relative to the Missouri municipal bond market by investing in tax-exempt Missouri municipal obligations that are underrated or undervalued or that represent municipal market sectors that are undervalued. The fund invests in municipal securities as well as floating rate securities, and derivatives such as futures, options, and swap contracts to the necessary extent.